SCHEMBL23385098

SCHEMBL23385098

C[C@H](CCCCCO)C1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 6/20 0.92
▸ GRIN2A Q12879 6/20 0.92
▸ OSBP P22059 6/20 0.82
▸ RORC P51449 5/20 0.82
▸ OSBP2 Q969R2 3/20 0.82
▸ USP2 O75604 1/20 0.82
▸ LMNA P02545 1/20 0.82
▸ ABCB1 P08183 1/20 0.82
▸ CYP46A1 Q9Y6A2 1/20 0.82
▸ NR1H3 Q13133 7/20 0.81
▸ DHCR24 Q15392 1/20 0.78
▸ CRYAB P02511 1/20 0.78
▸ HMGCR P04035 1/20 0.78
▸ ITGB3 P05106 1/20 0.78
▸ ITGAV P06756 1/20 0.78
▸ SREBF2 Q12772 1/20 0.78
▸ NPC1L1 Q9UHC9 1/20 0.78
▸ GRIN2B Q13224 5/20 0.77
▸ EPHA2 P29317 1/20 0.73
▸ NR1H2 P55055 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholesterol SCHEMBL21632297 0.96 OSBP (0.89) GRIN1GRIN2AOSBPRORCOSBP2
Cholesterol SCHEMBL28238054 0.96 OSBP (0.89) GRIN1GRIN2AOSBPRORCOSBP2
SCHEMBL17467018 0.96 GRIN1 (1.00) GRIN1GRIN2AOSBPRORCOSBP2
SCHEMBL14770959 0.96 GRIN1 (1.00) GRIN1GRIN2AOSBPRORCOSBP2
SCHEMBL14771078 0.96 GRIN1 (1.00) GRIN1GRIN2AOSBPRORCOSBP2
Cholesterol SCHEMBL27935905 0.95 OSBP (0.91) GRIN1GRIN2AOSBPRORCOSBP2
SCHEMBL21231086 0.92 OSBP (0.96) GRIN1GRIN2AOSBPRORCOSBP2
Octacosanol SCHEMBL28595297 0.92 OSBP (0.84) GRIN1GRIN2AOSBPRORCOSBP2
Cholesterol SCHEMBL27873562 0.92 OSBP (0.84) GRIN1GRIN2AOSBPRORCOSBP2
Cholesterol SCHEMBL27611626 0.92 OSBP (0.84) GRIN1GRIN2AOSBPRORCOSBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210145848-A1 OXYSTEROLS AND METHODS OF USE THEREOF SAGE THERAPEUTICS INC (US) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210145848-A1 OXYSTEROLS AND METHODS OF USE THEREOF NR1H3, NR1H2, HSD17B7 GRIN1 1881/4885GRIN2A 3308/4885OSBP 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback